Setrobuvir
Product Specifications
CAS Number
1071517-39-9
Target
DNA/RNA Synthesis, SARS-CoV, HCV Protease
Related Pathways
Microbiology/Virology, Proteases/Proteasome, DNA Damage/DNA Repair, Cell Cycle/Checkpoint
Purity
>99.99%
Bioactivity
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.
Smiles
C(N1[C@@]2([C@@]([C@@]3(C[C@]2(CC3)[H])[H])(C(O)=C(C1=O)C=4NC=5C(S(=O)(=O)N4)=CC(NS(C)(=O)=O)=CC5)[H])[H])C6=CC=C(F)C=C6
Molecular Formula
C25H25FN4O6S2
Molecular Weight
560.62
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1031257-01 0.02 mg (E-Coli)
Recombinant Burkholderia phytofirmans Flagellar brake protein YcgR 1 (ycgR1)
Sign In for Pricing
View Details MBS1031257-02 0.1 mg (E-Coli)
Recombinant Burkholderia phytofirmans Flagellar brake protein YcgR 1 (ycgR1)
Sign In for Pricing
View Details MBS1031257-03 0.02 mg (Yeast)
Recombinant Burkholderia phytofirmans Flagellar brake protein YcgR 1 (ycgR1)
Sign In for Pricing
View Details MBS1031257-04 0.1 mg (Yeast)
Recombinant Burkholderia phytofirmans Flagellar brake protein YcgR 1 (ycgR1)
Sign In for Pricing
View Details